Antiviral target analysis revealed that, while PA, PB1, PB2, NA, and M2 proteins are critical for influenza antiviral resistance development [25], no resistance-associated mutations were detected in the inhibitor-binding sites of PA, PB1, or PB2 in the studied strains (Figure 3). The gene discussed is XK; the disease is influenza.